These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 38881940)
1. Construction of a prognostic score model for breast cancer based on multi-omics analysis of study on bone metastasis. Ren H; Shen X; Xie M; Guo X Transl Cancer Res; 2024 May; 13(5):2419-2436. PubMed ID: 38881940 [TBL] [Abstract][Full Text] [Related]
2. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
4. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer. Du XJ; Yang XR; Wang QC; Lin GL; Li PF; Zhang WF Heliyon; 2023 Feb; 9(2):e13185. PubMed ID: 36747547 [TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma. Yue C; Ma H; Zhou Y PeerJ; 2019; 7():e8128. PubMed ID: 31803536 [TBL] [Abstract][Full Text] [Related]
7. A glycolysis-related signature to improve the current treatment and prognostic evaluation for breast cancer. Feng S; Ning L; Zhang H; Wang Z; Lu Y PeerJ; 2024; 12():e17861. PubMed ID: 39119106 [TBL] [Abstract][Full Text] [Related]
8. Enhancer RNA SLIT2 Inhibits Bone Metastasis of Breast Cancer Through Regulating P38 MAPK/c-Fos Signaling Pathway. Li P; Lin Z; Liu Q; Chen S; Gao X; Guo W; Gong F; Wei J; Lin H Front Oncol; 2021; 11():743840. PubMed ID: 34722297 [TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis. Yang Y; Li Z; Zhong Q; Zhao L; Wang Y; Chi H Gland Surg; 2022 May; 11(5):892-912. PubMed ID: 35694087 [TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer. Pei J; Li Y; Su T; Zhang Q; He X; Tao D; Wang Y; Yuan M; Li Y Front Genet; 2020; 11():912. PubMed ID: 33193571 [No Abstract] [Full Text] [Related]
11. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling. Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481 [TBL] [Abstract][Full Text] [Related]
12. A seven-nuclear receptor-based prognostic signature in breast cancer. Wu F; Chen W; Kang X; Jin L; Bai J; Zhang H; Zhang X Clin Transl Oncol; 2021 Jul; 23(7):1292-1303. PubMed ID: 33210236 [TBL] [Abstract][Full Text] [Related]
13. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma. Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X Front Oncol; 2023; 13():1182434. PubMed ID: 37346073 [TBL] [Abstract][Full Text] [Related]
14. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes. Yan C; Liu Q; Jia R Front Oncol; 2022; 12():829045. PubMed ID: 35186763 [TBL] [Abstract][Full Text] [Related]
15. A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer. Xu S; Liu Y; Ma H; Fang S; Wei S; Li X; Lu Z; Zheng Y; Liu T; Zhu X; Xu D; Pan Y Front Genet; 2022; 13():834731. PubMed ID: 35432482 [No Abstract] [Full Text] [Related]
16. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation. Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414 [TBL] [Abstract][Full Text] [Related]
17. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
18. Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study. Chen L; Zhang X; Lin J; Wen Y; Chen Y; Chen CB Ann Transl Med; 2022 Dec; 10(24):1316. PubMed ID: 36660709 [TBL] [Abstract][Full Text] [Related]
19. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma]. Zhou J; Wang X; Li Z; Jiang R Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900 [TBL] [Abstract][Full Text] [Related]
20. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases. Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]